Where translation falls short in practice
June 10, 2026 | Localisation, clinical trial, translation
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
Running global clinical trials requires clear communication with participants. Every detail needs to land as intended. But a technically accurate translation may still fall short, creating avoidable barriers for participants and adding clarification burdens for site staff.
This is the gap between translated material and content that is genuinely understood. While standard translation focuses on linguistic accuracy, expert localisation adapts the meaning, context and tone so it works for the intended audience.
Accuracy does not guarantee understanding
So, what if the translation is technically correct but the participant still has to ask the site team what it really means? This is where localisation becomes essential.
It would be easy to assume a correctly translated sentence automatically conveys the intended meaning. In clinical research, this assumption can create challenges.
Before localisation even begins, we carefully craft the master document with the right tone, turning complex medical language into clear, plain English. Right from the start, this approach helps make our materials easier to understand. Once that solid foundation is set, our localisation experts adapt the content for each target language, making sure phrasing and sentence structures flow naturally while preserving the necessary medical accuracy. Ultimately, this process bridges the gap between technical correctness and real participant understanding.
How tone and intent shift across borders
Language is deeply tied to culture. What sounds polite and encouraging in one country might sound demanding or inappropriately casual in another.
For example, in some cultures, participant-facing materials are expected to use highly formal language, while in others a more conversational, approachable style is preferred. If materials written in plain English are directly translated without adapting the tone, they can come across as either too informal or overly authoritative, depending on the context. Localising content carefully adapts not just the words but the underlying intent, making sure it resonates with local expectations and, most importantly, helps foster participant trust.
Why right can still feel wrong
Even with perfect grammar, content can still feel unnatural. Best-practice research on translation and cultural adaptation in clinical studies has long shown that concepts and phrasing may need to be adapted, not just translated, to remain meaningful and relevant for the target audience. A recent study by Gregório et al. (2025) is one of many to evidence this.
Idiomatic expressions or metaphors used to explain how a drug works rarely cross borders intact. A ‘lock and key’ metaphor makes perfect sense to an English speaker, but it might have a totally different meaning in another region.
When trial participants read materials that feel distinctly foreign, they may question if the trial truly understands their needs. It’s vital that every piece of information reads as if it were written specifically for that local participant, in their own cultural context.
Spotting the warning signs
Poor translation can create operational challenges long before participants raise concerns directly. Trial teams may see the impact in added site queries, slower consent processes, misunderstandings around trial requirements and, over time, risks to protocol adherence and retention.
The value of getting it right
Standard translation gets your words across the border, but strategic localisation gets your meaning into the hands of the participant. We pride ourselves on delivering localised clinical trial materials that minimise confusion, reduce operational challenges and keep trials running smoothly.
Recognising where translation falls short is the first step. Next, we’ll look at what effective localisation actually looks like in practice.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there’s still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.
Clarity in clinical trials
Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.
Caring for patients’ mental health in clinical trials
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Driving equitable healthcare: The role of DE&I in clinical trials
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and…
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial…
New report now available: Integrating ‘patient first’ into medicine development
A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map…
The digital prescription – enhancing the patient experience with technology
We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.
Compliance — a driving force for influencing public perceptions of the pharma industry?
How does compliance play into public perceptions of pharma and why is it important for improving public opinion?